Eysuvius

With positive key trial, Kala Pharma's dry eye drug Eysuvis emulates approval path set by Xiidra
Endpoints
Mon, 03/9/20 - 10:07 am
Kala Pharma
Eysuvius
dry eye disease
clinical trials